Journal list menu
Alzheimer's & Dementia
Editor-in-Chief: Zaven S. Khachaturian, PhD
Executive Editor: Ara S. Khachaturian, PhD
About the Journal
Alzheimer’s & Dementia® aims to bridge the knowledge gaps across a wide range of bench-to-bedside investigation in dementia and Alzheimer's Disease.
Article featured in the August issue of Alzheimer’s & Dementia:
- COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US
- Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study
- Deepen into sleep and wake patterns across Alzheimer's disease phenotypes
- Association of life-course depression with the risk of dementia in late life: A nationwide twin study
Article featured in the September issue of Alzheimer’s & Dementia:
- Head injury and 25-year risk of dementia
- Investigating the association between cancer and the risk of dementia: Results from the Memento cohort
- Replication study of plasma proteins relating to Alzheimer's pathology
- Midlife vascular risk factors and risk of incident dementia: Longitudinal cohort and Mendelian randomization analyses in the UK Biobank
Article featured in the October issue of Alzheimer’s & Dementia:
- Associations of loneliness with risk of Alzheimer's disease dementia in the Framingham Heart Study
- Early prevention of cognitive impairment in the community population: The Beijing Aging Brain Rejuvenation Initiative
- Functional decline in the aphasic variant of Alzheimer's disease
- Quantifying progression in primary progressive aphasia with structural neuroimaging
Articles
Alzheimer's Disease Interventions: Implications of therapeutic promises amidst questions and doubts about clinically meaningful outcomes
- 1591-1594
- 30 October 2021
Concussion and long‐term cognitive function among rugby players—The BRAIN Study
- 20 October 2021
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- 263-269
- 22 April 2011
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
- 535-562
- 1 April 2018
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- 270-279
- 22 April 2011
The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning
- Alzheimer's & Dementia
- 1056-1065
- 5 January 2021
Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
- Alzheimer's & Dementia
- 696-701
- 1 November 2020
COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US
- Alzheimer's & Dementia
- 1297-1306
- 9 February 2021
Altmetric measures the online attention that an article receives. Click here to view the latest trending articles from Alzheimer’s & Dementia based on attention in the past week.
The list below shows the top 3 Alzheimer’s & Dementia articles based on all-time Altmetric scores:
Recent issues
Latest news
Stay Connected with the Alzheimer’s Association®
The Alzheimer’s Association® advances research to end Alzheimer’s and dementia while enhancing care for those living with the diseases. The Alzheimer’s Association is the largest non-profit funder of Alzheimer’s disease research. Its mission is “to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health”.
- ISTAART
- AAIC Conference
- International Grant Program
- TrialMatch
- Research Program
- About the Association
Follow the Alzheimer’s Association®:
Published on behalf of the
Search articles from all three publications, and keep up with the latest information on the Alzheimer's Association® journal hub page.
Go to the society hub >>
Companion Journals
Read the 2021 Alzheimer's disease facts and figures HERE
View the infographic HERE
ALZHEIMER'S DRUG DEVELOPMENT & FUNDING
Read the 2021 Alzheimer's Disease Drug Development Pipeline HEREView the infographic HERE
- Virtual Issue: World Wide FINGERS Publications
- Special Topic Issue: Psychosocial Measures
- Special Topic Section: Alzheimer's Disease Among Adults with Down Syndrome
Calls for Papers
- Call for Papers: TRCI Special Topic Issue: Psychosocial Measures
- Call for Papers: DADM Special Topic Section: Cognitive Decline, Mild Cognitive Impairment, Alzheimer’s disease and related dementias among Latinos
- Call for Papers: DADM Special Topic Section: Digital Biomarkers for Alzheimer Disease and Related Dementias
- Call for Papers: DADM Special Topic Section: Synergistic effects of both individual differences and modifiable risk factors on AD progression
Stay Connected with the Alzheimer's Association ®
The Alzheimer’s Association® advances research to end Alzheimer’s and dementia while enhancing care for those living with the diseases. The Alzheimer’s Association is the largest non-profit funder of Alzheimer’s disease research. Its mission is “to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health”.
- ISTAART
- AAIC Conference
- International Grant Program
- TrialMatch
- Research Program
- About the Association
Follow the Alzheimer’s Association®:
